www.uhasselt.be
DSpace

Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/11006

Title: Current primary care practice in the diagnosis and management of patients with suspected venous thromboembolism and prescription of inibition dose of Enoxaparin
Authors: Verhamme, P.
Motte, S.
CLAES, Neree
Verhaeghe, R.
Hermans, C.
Issue Date: 2010
Publisher: EDIZIONI MINERVA MEDICA
Citation: INTERNATIONAL ANGIOLOGY, 29 (1). p. 58-63
Abstract: Aim. Ambulatory care of patients with deep vein thrombosis (DVT) has been well validated but limited data exist on the diagnostic and therapeutic management of venous thromboembolism (VTE) in primary care. Methods. A cross-sectional survey on the clinical conditions for the initiation of once daily (OD) enoxaparin and on the diagnostic and therapeutic strategy of VTE in ambulatory patients using a single-visit questionnaire to be filled out by the general practitioner (GP). Results. Of the 4522 included patients, 2164 (48%) were started on therapeutic OD enoxaparin for confirmed or suspected proximal DVT, 464 (10%) for distal DVT, 493 (11%) for pulmonary embolism (PE), and 742 (16%) for superficial venous thrombosis (SVT). Further indications included bridging of oral anticoagulation in 173 patients (4%), atrial fibrillation in 77 patients (2%) and prevention VTE in 78 patients (2%). Enoxaparin was initiated on the basis of clinical probability before objective confirmation in 17%, 33%, 53% and 69% of patients with a diagnosis of PE, proximal DVT, distal DVT and SVT, respectively. No objective testing was planned for 3%, 9%, 18% and 41% of patients in these respective categories. Patients were referred to specialist care in 88%, 49%, 42% and 21% of patients with PE, proximal DVT, distal DVT and SVT, respectively. Conclusion. Therapeutic OD enoxaparin is prescribed in primary care for the whole clinical spectrum of VTE. However, the diagnostic work-up is unsatisfactory to suboptimal in a substantial proportion of these patients. [Int Angiol 2010;29:58-63]
Notes: [Verhamme, P.] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Vasc Med & Haemostasis, B-3000 Louvain, Belgium. [Motte, S.] Free Univ Brussels, Hop Erasme, Serv Pathol Vasc, B-1070 Brussels, Belgium. [Claes, N.] Univ Hasselt, Fac Med, Diepenbeek, Belgium. [Verhaeghe, R.; Hermans, C.] Clin Univ St Luc, Div Haematol, Haemostasis & Thrombosis Unit, B-1200 Brussels, Belgium. Peter.Verhamme@uz.kuleuven.be
URI: http://hdl.handle.net/1942/11006
ISI #: 000277830600009
ISSN: 0392-9590
Category: A1
Type: Journal Contribution
Validation: ecoom, 2011
Appears in Collections: Research publications

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.